Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: '584/MMP

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

milestone

Rank: President [?]

Points: 18650 [?]

Votes: 158 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: '584/MMP - Milestone SGE1

in response to

Re: '584/MMP - Milestone

SGE1

posted on Nov 20, 2007 04:31PM

Are you suggesting that in the presumed settlement negotiations, they're haggling over the value of the '584 and other patents that aren't even part of this litigation?

Not at all, I'm suggesting that once there is settlement on past infringement of the '148 and '336, the Defendants will need to license the MMP Portfolio. There is a difference.